Emerging Markets
PIH Emerging Markets focuses on the specialized needs of the emerging world, bringing Pfizer's portfolio of innovative medicines and vaccines to patients and people in more than 100 markets across Latin America, Africa, Middle East and Asia.
Through unique commercial models and innovative partnerships, our goal is to accelerate access to the Pfizer portfolio and make a meaningful difference in the health and well-being of the more than 5 billion people living in these regions.
In 2018, the PIH Emerging Markets team obtained approval and launched almost 70 innovative medicines and vaccines across our markets.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families